Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert M Spaapen

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Immunological Methods|February 16, 2018
CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement researchAstrid J F Thielen, Iris M van Baarsen, Marlieke L Jongsma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
Functional characteristics of the high affinity IgG receptor, FcγRICees E van der Poel, Robbert M Spaapen, Jan G J van de Winkel, et al.
Frontiers in Immunology|March 1, 2024
Isolation and expansion of pure and functional γδ T cellsTamara Verkerk, Anouk T Pappot, Tineke Jorritsma, et al.
Haematologica|August 24, 2014
Identification of minor histocompatibility antigens based on the 1000 Genomes ProjectRimke Oostvogels, Henk M Lokhorst, Monique C Minnema, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2021
Soluble FAS Ligand Enhances Suboptimal CD40L/IL-21-Mediated Human Memory B Cell Differentiation into Antibody-Secreting CellsSaskia D van Asten, Peter-Paul Unger, Casper Marsman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Rapid identification of clinical relevant minor histocompatibility antigens via genome-wide zygosity-genotype correlation analysisRobbert M Spaapen, Ron A L de Kort, Kelly van den Oudenalder, et al.
The Journal of Experimental Medicine|November 13, 2008
Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysisRobbert M Spaapen, Henk M Lokhorst, Kelly van den Oudenalder, et al.
Immunity|November 9, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Xiufen Chen, Sravya Tumuluru, et al.
Immunity|May 26, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Sravya Tumuluru, Xiufen Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculatureRobbert M Spaapen, Michael Y K Leung, Mercedes B Fuertes, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Immunological Methods|February 16, 2018
CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement researchAstrid J F Thielen, Iris M van Baarsen, Marlieke L Jongsma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
Functional characteristics of the high affinity IgG receptor, FcγRICees E van der Poel, Robbert M Spaapen, Jan G J van de Winkel, et al.
Frontiers in Immunology|March 1, 2024
Isolation and expansion of pure and functional γδ T cellsTamara Verkerk, Anouk T Pappot, Tineke Jorritsma, et al.
Haematologica|August 24, 2014
Identification of minor histocompatibility antigens based on the 1000 Genomes ProjectRimke Oostvogels, Henk M Lokhorst, Monique C Minnema, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2021
Soluble FAS Ligand Enhances Suboptimal CD40L/IL-21-Mediated Human Memory B Cell Differentiation into Antibody-Secreting CellsSaskia D van Asten, Peter-Paul Unger, Casper Marsman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Rapid identification of clinical relevant minor histocompatibility antigens via genome-wide zygosity-genotype correlation analysisRobbert M Spaapen, Ron A L de Kort, Kelly van den Oudenalder, et al.
The Journal of Experimental Medicine|November 13, 2008
Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysisRobbert M Spaapen, Henk M Lokhorst, Kelly van den Oudenalder, et al.
Immunity|November 9, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Xiufen Chen, Sravya Tumuluru, et al.
Immunity|May 26, 2022
Dendritic cells can prime anti-tumor CD8<sup>+</sup> T cell responses through major histocompatibility complex cross-dressingBrendan W MacNabb, Sravya Tumuluru, Xiufen Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculatureRobbert M Spaapen, Michael Y K Leung, Mercedes B Fuertes, et al.
Pageof 4